Local recurrence after surgery for primary extra-abdominal desmoid-type fibromatosis

British Journal of Surgery

Volumn 100, Issue 9, 2013, Pages 1214-1219

  Van Broekhoven, D L M ^a   Verhoef, C ^d   Elias, S G ^b   Witkamp, A J ^c   Van Gorp, J M H H ^a   Van Geel, B A N ^d   Wijrdeman, H K ^c   Van Dalen, T ^a  

^a DEPARTMENT OF SURGERY   (Netherlands)

^b General Practice   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DISEASE COURSE; FEMALE; FIBROMATOSIS; HUMAN; INFANT; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; TUMOR RECURRENCE; TUMOR VOLUME; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; FIBROMATOSIS, AGGRESSIVE; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TUMOR BURDEN; YOUNG ADULT;

EID: 84880134210     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9194     Document Type: Article

References (26)

1. Reitamo JJ, Häyry P, Nykyri E, Saxén E,. The desmoid tumour. I. Incidence, sex- age- and anatomical distribution in the Finnish population. Am J Clin Pathol 1982; 77: 665-673.
2. Nieuwenhuis MH, Lefevre JH, Bülow S, Järvinen H, Bertario L, Kernéis S, et al. Family history, surgery and APS mutation are risk factors for desmoid tumours in familial adenomatous polyposis: an international cohort study. Dis Colon Rectum 2011; 54: 1229-1234.
3. Mitchell G, Thomas JM, Harmer CL,. Aggressive fibromatosis: evidence for a stable phase. Sarcoma 1998; 2: 149-154.
4. Baumert BG, Spahr MO, Von Hochstetter A, Beauvois S, Landmann C, Fridrich K, et al. The impact of radiotherapy in the treatment of desmoid tumours. An international survey of 110 patients. A study of the rare cancer network. Radiat Oncol 2007; 2: 12.
5. Salas S, Dufresne A, Bui B, Blay JY, Terrier P, Ranchere-Vince D, et al. Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation. J Clin Oncol 2011; 29: 3553-3558.
6. De Bree E, Keus R, Melissas J, Tsiftsis D, van Coevorden F,. Desmoid tumors: need for an individualized approach. Expert Rev Anticancer Ther 2009; 9: 525-535.
7. Hansmann A, Adolph C, Vogel T, Unger A, Moeslein G,. High-dose tamoxifen and sulindac as first-line treatment for desmoids tumors. Cancer 2004; 100: 612-620.
8. De Camargo VP, Keohad ML, D'Adamo DR, Antonescu CR, Brennan MF, Singer S, et al. Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor). Cancer 2010; 116: 2258-2265.
9. Nuyttens JJ, Rust PF, Thomas CR Jr, Turrisi AT III,. Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: a comparative review of 22 articles. Cancer 2000; 88: 1517-1523.
10. Huang K, Fu H, Shi YQ, Zhou Y, Du CY,. Prognostic factors for extra-abdominal and abdominal wall desmoids: a 20-year experience at a single institution. J Surg Oncol 2009; 100: 563-569.
11. Guadagnolo BA, Zagars GK, Ballo MT,. Long-term outcomes for desmoid tumors treated with radiation therapy. Int J Radiat Oncol Biol Phys 2008; 71: 441-447.
12. Stoeckle E, Coindre JM, Longy M, Binh MB, Kantor G, Kind M, et al. A critical analysis of treatment strategies in desmoid tumours: a review of a series of 106 cases. Eur J Surg Oncol 2009; 35: 129-134.
13. Peng PD, Hyder O, Mavros MN, Turley R, Groeschl R, Firoozmand A, et al. Management and recurrence patterns of desmoids tumors: a multi-institutional analysis of 211 patients. Ann Surg Oncol 2012; 19: 4036-4042.
14. Pencavel T, Strauss DC, Thomas JM, Hayes AJ,. The surgical management of soft tissue tumours arising in the abdominal wall. Eur J Surg Oncol 2010; 36: 489-495.
15. Bertani E, Chiappa A, Testori A, Mazzarol G, Biffi R, Martella S, et al. Desmoid tumors of the anterior abdominal wall: results from a monocentric surgical experience and review of the literature. Ann Surg Oncol 2009; 16: 1642-1649.
16. Ballo MT, Zagars GK, Pollack A, Pisters PW, Pollack RA,. Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol 1999; 17: 158-167.
17. Gluck I, Griffith KA, Biermann JS, Feng FY, Lucas DR, Ben-Josef E,. Role of radiotherapy in the management of desmoid tumors. Int J Radiat Oncol Biol Phys 2011; 80: 787-792.
18. Rüdiger HA, Ngan SY, Ng M, Powell GJ, Choong PF,. Radiation therapy in the treatment of desmoid tumours reduces surgical indications. Eur J Surg Oncol 2010; 36: 84-88.
19. Keus RB, Nout RA, Blay JY, de Jong JM, Saran F, Sokal M, et al. Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis-EORTC 62991-22998. The Connective Tissue Oncology Society Meeting, Prague, November 2012.
20. Jelinek JA, Stelzer KJ, Conrad E, Bruckner J, Kliot M, Koh W, et al. The efficacy of radiotherapy as postoperative treatment for desmoid tumors. Int J Radiat Oncol Biol Phys 2001; 50: 121-125.
21. Gronchi A, Casali PG, Mariani L, Lo Vullo S, Colecchia M, Lozza L, et al. Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol 2003; 21: 1390-1397.
22. Bonvalot S, Eldweny H, Haddad V, Rimareix F, Missenard G, Oberlin O, et al. Extra-abdominal primary fibromatosis: aggressive management could be avoided in a subgroup of patients. Eur J Surg Oncol 2008; 34: 462-468.
23. Fiore M, Rimareix F, Mariani L, Domont J, Collini P, Le Péchoux C, et al. Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment. Ann Surg Oncol 2009; 16: 2587-2593.
24. Nishida Y, Tsukushi S, Shido Y, Wasa J, Ishiguro N, Yamada Y,. Successful treatment with meloxicam, a cyclooxygenase-2 inhibitor, of patients with extra-abdominal desmoid tumors: a pilot study. J Clin Oncol 2010; 28: e107-e109.
25. Garbay D, Le Cesne A, Penel N, Chevreau C, Marec-Berard P, Blay JY, et al. Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG). Ann Oncol 2012; 23: 182-186.
26. Chugh R, Wathen JK, Patel SR, Maki RG, Meyers PA, Schuetze SM, et al. Efficacy of imatinib in aggressive fibromatosis: results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial. Clin Cancer Res 2010; 16: 4884-4891.